Human Reproduction · 2005 · 32 citations · 41 references
Life SciencesGynecologyImmunologyInflammationReproductive ImmunologyReproductive PhysiologyCytokines In ReproductionEndometrial ImmunologyEndometriosisCytokines In Endometrial ReceptivityDecoy ReceptorsEndometriosis-associated Endometrial ImmunologyMatrix Metalloproteinase ProcessingPost-translational ModulationWestern Blotting
Numerous functional changes were observed in the intrauterine endometrial tissue of women with endometriosis. Our previous studies revealed a marked decrease in the expression of interleukin-1 receptor type 2 (IL-1RII), a decoy receptor known for its ability to buffer IL-1 effects. The aim of the present study was to assess whether post-translational mechanisms such as proteolysis may contribute to the down-regulation of IL-1RII levels. Our data showed that soluble IL-1RII (sIL-1RII) concentrations released by freshly cultured endometrial tissue were significantly lower in women with endometriosis than in normal women (P < 0.01) and further revealed a statistically significant correlation between increased proteolysis and decreased sIL-1RII levels (P < 0.05; r = -0.47). (125)I-labelled soluble recombinant human IL-1RII ([(125)I]srhIL-1RII) was significantly more degraded in culture supernatant of tissues from women with endometriosis compared to normal women (P < 0.05), and natural tissue inhibitor of matrix metalloproteinase (TIMP)-1 inhibited [(125)I]srhIL-1RII degradation. Incubation of srhIL-1RII with active rhMMP-9 resulted in a dose-dependent degradation of srhIL-1RII as analysed by western blotting. Dual immunofluorescence showed an increased immunostaining for matrix metalloproteinase-9 in situ in the endometrial tissue of women with endometriosis compared to normal women and a decreased immunostaining for IL-1RII. The present study showed a reduced release of sIL-1RII by the endometrial tissue of women with endometriosis and revealed a proteolytic post-translational mechanism which may be involved in the down-regulation of IL-1RII levels. This may enhance IL-1-mediated activation of endometrial cells and contribute to the local immuno-inflammatory process observed in endometriosis patients.
41
Interleukin-1 Type II Receptor: A Decoy Target for IL-1 That Is Regulated by IL-4
Francesco Colotta, Fabio Re, Marta Muzio et al. · Science · 1993 · 982 citations
Life Sciences, Immunology, Pathology +15
R. W. Noyes, Arthur T. Hertig, John A. Rock · American Journal of Obstetrics and Gynecology · 1975 · 953 citations
Medicine, Gynecology, Pathology +7